Found: 8
Select item for more details and to access through your institution.
Clinical Relevance of Physical Function Outcomes in Cancer Cachexia.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1395, doi. 10.3390/cancers16071395
- By:
- Publication type:
- Article
Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 01, doi. 10.3389/fcimb.2024.1297321
- By:
- Publication type:
- Article
A Review of Nutraceuticals in Cancer Cachexia.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3884, doi. 10.3390/cancers15153884
- By:
- Publication type:
- Article
EXT418, a novel long‐acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 3, p. 1337, doi. 10.1002/jcsm.13211
- By:
- Publication type:
- Article
Transmigration of Trypanosoma cruzi trypomastigotes through 3D cultures resembling a physiological environment.
- Published in:
- Cellular Microbiology, 2020, v. 22, n. 8, p. 1, doi. 10.1111/cmi.13207
- By:
- Publication type:
- Article
The protein family TcTASV-C is a novel Trypanosoma cruzi virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 5, p. 1, doi. 10.1371/journal.pntd.0006475
- By:
- Publication type:
- Article
EXECUÇÃO DE PILARES DE CONCRETO ARMADO MOLDADOS IN-LOCO E SUAS POSSÍVEIS MANIFESTAÇÕES PATOLÓGICAS.
- Published in:
- UNINGÁ Review, 2016, v. 28, n. 3, p. 16
- By:
- Publication type:
- Article
TcTASV-C, a Protein Family in <i>Trypanosoma cruzi</i> that Is Predominantly Trypomastigote-Stage Specific and Secreted to the Medium.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0071192
- By:
- Publication type:
- Article